Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Prostaglandins & Other Lipid Mediators|November 25, 2003
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiologyDavid Sacerdoti, Angelo Gatta, John C McGiffWorld Journal of Gastroenterology|January 21, 2017
Clinical role of non-invasive assessment of portal hypertensionMassimo Bolognesi, Marco Di Pascoli, David SacerdotiProstaglandins & Other Lipid Mediators|June 30, 2016
EETs and HO-1 cross-talkDavid Sacerdoti, Paola Pesce, Marco Di Pascoli, et al.Frontiers in Pharmacology|March 7, 2022
Platelets in Non-alcoholic Fatty Liver DiseaseAndrea Dalbeni, Marco Castelli, Mirko Zoncapè, et al.Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|March 7, 2019
Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophyFrancesco Francini-Pesenti, Giorgia Querin, Cristina Martini, et al.American Journal of Physiology. Renal Physiology|July 3, 2009
Heme oxygenase: the key to renal function regulationNader G Abraham, Jian Cao, David Sacerdoti, et al.Journal of Vascular Research|April 14, 2017
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver CirrhosisMarco Di Pascoli, David Sacerdoti, Patrizia Pontisso, et al.International Journal of Hypertension|April 14, 2012
Role of HO/CO in the Control of Peripheral Circulation in HumansDavid Sacerdoti, Despina Mania, Paola Pesce, et al.Ultrasound in Medicine & Biology|February 14, 2004
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: relationships with splanchnic haemodynamicsLuisa Spadaro, Massimo Bolognesi, Alessandra Pierobon, et al.Prostaglandins & Other Lipid Mediators|August 23, 2011
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertensionDavid Sacerdoti, Houli Jiang, Silvia Gaiani, et al.Pageof 9